421 related articles for article (PubMed ID: 15024333)
1. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin injections for children with excessive drooling.
Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin A as a treatment for excessive drooling in children.
Bothwell JE; Clarke K; Dooley JM; Gordon KE; Anderson R; Wood EP; Camfield CS; Camfield PR
Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968
[TBL] [Abstract][Full Text] [Related]
4. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
5. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
[TBL] [Abstract][Full Text] [Related]
6. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
Alrefai AH; Aburahma SK; Khader YS
Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
[TBL] [Abstract][Full Text] [Related]
7. Effects of salivary gland botulinum Toxin-A on drooling and respiratory morbidity in children with neurological dysfunction.
Gubbay A; Marie Blackmore A
Int J Pediatr Otorhinolaryngol; 2019 Sep; 124():124-128. PubMed ID: 31185343
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
Jongerius PH; Rotteveel JJ; van den Hoogen F; Joosten F; van Hulst K; Gabreëls FJ
Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A as treatment for drooling saliva in PD.
Pal PK; Calne DB; Calne S; Tsui JK
Neurology; 2000 Jan; 54(1):244-7. PubMed ID: 10636161
[TBL] [Abstract][Full Text] [Related]
11. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.
Reid SM; Walstab JE; Chong D; Westbury C; Reddihough DS
J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review.
Calim OF; Hassouna HNH; Yildirim YS; Dogan R; Ozturan O
Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):104-112. PubMed ID: 30371109
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
[TBL] [Abstract][Full Text] [Related]
14. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
Hay N; Penn C
Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Wilken B; Aslami B; Backes H
Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy.
Lin YC; Shieh JY; Cheng ML; Yang PY
Neurology; 2008 Jan; 70(4):316-8. PubMed ID: 18209205
[No Abstract] [Full Text] [Related]
17. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
Jongerius PH; Rotteveel JJ; van Limbeek J; Gabreëls FJ; van Hulst K; van den Hoogen FJ
Neurology; 2004 Oct; 63(8):1371-5. PubMed ID: 15505151
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin-A injections vs radiotherapy for drooling in ALS.
Weikamp JG; Schinagl DA; Verstappen CC; Schelhaas HJ; de Swart BJ; Kalf JG
Acta Neurol Scand; 2016 Sep; 134(3):224-31. PubMed ID: 26803950
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
Reid SM; Johnstone BR; Westbury C; Rawicki B; Reddihough DS
Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
[TBL] [Abstract][Full Text] [Related]
20. The impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study.
Sales HF; Cerqueira C; Vaz D; Medeiros-Rios D; Armani-Franceschi G; Lucena PH; Sternberg C; Nóbrega AC; Luz C; Fonseca D; Carvalho AL; Monteiro L; Siqueira IC; Bandeira ID; Lucena R
Neurol Res; 2021 Jan; 43(1):54-60. PubMed ID: 32915712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
